undamentalytics Newsletter

Balchem Corp balance sheet

At the end of fiscal 2025, Balchem Corp had total assets of $1.69bn, total liabilities of $429m and shareholders' equity of $1.26bn. It held $74.6m in cash against $164m of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Balchem Corp: balance sheet, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents4677115145209508539405466851036764507566
Receivables—32344239726083911009398117132125120144146
Inventory—161921255046576167847191120110131131177
Total current assets—130176212278181198188199226255267322336314314366405
Goodwill—29292929384384440441448524529524770779780816807
Total assets1882292723133778628809499649811,1561,1661,1991,6251,5971,5751,6861,704
Total current liabilities—303130369681101108829294144140148158176164
Short-term debt—11003535353502———————
Long-term debt—30002982612260156————————
Total debt05434298296261219156251164109441310190164124
Total liabilities—41404046470416428347290412338322686543425429377
Shareholders' equity1471872322733313924645216176927448288779381,0541,1501,2571,327
Shares outstanding—29m29m29m30m31m32m32m32m32m32m32m32m32m32m33m32m32m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BCPC vs HWKNALTO vs BCPCBCPC vs ECVTBCPC vs PRM

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Balchem Corp's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Balchem Corp.